Enfermedades inflamatorias y neoplásicas del tracto gastrointestinal, enfermedades hepáticas prevalentes
ENGASTRO
Hospital Universitario Pío del Río Hortega
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Pío del Río Hortega (6)
2020
-
Variation in Colonoscopy Performance Measures According to Procedure Indication
Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 5, pp. 1216-1223.e2
2019
-
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 42, Núm. 9, pp. 579-592
-
Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update
Gastroenterologia y Hepatologia, Vol. 42, Núm. 3, pp. 188-201
-
Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain
PLoS ONE, Vol. 14, Núm. 11
2015
-
High efficacy and safety of triple therapy in hcv genotype 1 and moderate fibrosis: A multicenter study of clinical practice in Spain
Annals of Hepatology, Vol. 14, Núm. 4, pp. 477-486
2011
-
Clinical patterns and outcomes of ischaemic colitis: Results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)
Scandinavian Journal of Gastroenterology, Vol. 46, Núm. 2, pp. 236-246